Know Cancer

or
forgot password

Measurement of Biomarkers of Bone Resorption in Patients With Hormone Sensitive Bone Metastases From Prostate Cancer Treated With Antiandrogen Therapy and Bisphosphonates


N/A
40 Years
80 Years
Open (Enrolling)
Male
Metastatic Prostate Cancer

Thank you

Trial Information

Measurement of Biomarkers of Bone Resorption in Patients With Hormone Sensitive Bone Metastases From Prostate Cancer Treated With Antiandrogen Therapy and Bisphosphonates


Inclusion Criteria:



- prostate cancer with bone metastases

- hormone sensitive

Exclusion Criteria:

- inadequate renal function

- ongoing dental problems

- previous bisphosphonate therapy

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Principal Investigator

Donald Bissett, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

NHS Grampian

Authority:

United Kingdom: Research Ethics Committee

Study ID:

10/S0802/36

NCT ID:

NCT01233557

Start Date:

September 2010

Completion Date:

August 2015

Related Keywords:

  • Metastatic Prostate Cancer
  • Bone Resorption
  • Prostatic Neoplasms

Name

Location